Cargando…

Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study

BACKGROUND: An estimated 10 million people in the USA are immunocompromised, a risk factor for severe COVID-19. Data informing whether immune-mediated medications lead to more severe infection are sparse. OBJECTIVE: Determine whether outpatient immunosuppressive therapies that treat autoimmune infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Velayos, Fernando S., Dusendang, Jennifer R., Schmittdiel, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477718/
https://www.ncbi.nlm.nih.gov/pubmed/34581984
http://dx.doi.org/10.1007/s11606-021-07152-2